Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genomics in the real world.

S R Wiley1

  • 1Abbott Laboratories, Abbott Park, IL 60064, USA.

Current Pharmaceutical Design
|April 10, 1999
PubMed
Summary
This summary is machine-generated.

Genomics offers great promise for drug discovery, but its full impact is emerging as new technologies integrate. Investing in genomics and functional genomics accelerates target validation and improves drug development success rates.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Survey of Blemishes on Processed Microfilm.

Journal of research of the National Bureau of Standards. Section A, Physics and chemistry·2020
Same author

A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis.

Immunity·2001
Same author

IFN-gamma mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression.

Journal of immunology (Baltimore, Md. : 1950)·1999
Same author

Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL.

The Journal of experimental medicine·1999
Same author

TWEAK induces angiogenesis and proliferation of endothelial cells.

The Journal of biological chemistry·1999
Same author

Estrogen-related receptor alpha 1 functionally binds as a monomer to extended half-site sequences including ones contained within estrogen-response elements.

Molecular endocrinology (Baltimore, Md.)·1997

Area of Science:

  • Genomics and Bioinformatics
  • Drug Discovery and Development
  • Pharmaceutical Industry

Background:

  • Genomics has become a broad term for data-intensive biological methods.
  • The pharmaceutical industry anticipates significant benefits from genomics, though widespread impact on drug discovery is still developing.

Purpose of the Study:

  • To explore the evolving role and impact of genomics in the drug discovery pipeline.
  • To highlight the necessity of integrating genomic data and functional genomics technologies for accelerated target validation.

Main Methods:

  • Analysis of the integration of genomic data into drug discovery programs.
  • Development and application of functional genomics technologies for predicting compound effects.
  • Investment in biological research infrastructure for handling large-scale sequence data.

Related Experiment Videos

Main Results:

  • Extracting novel biological targets from extensive sequence data requires substantial time and investment.
  • Functional genomics technologies are being developed to predict the efficacy of inhibitory compounds early in development.
  • Early-stage exploratory research in genomics can enhance the success rates of screening and medicinal chemistry.

Conclusions:

  • The impact of genomics on drug discovery will gradually materialize as integration improves.
  • Significant investment in infrastructure and functional genomics is crucial for accelerating target validation and improving drug development efficiency.